PRE-MARKET INDIAN STOCKS NEWS: Earnings from Lupin, MCX and NSE

Bata India (BATA IN) - Co. Q2 (INR) net rose 28.6% Y/Y to 180mln, EBITDA fell 0.7% Y/Y to 1.44bln, rev. rose 7.6% Y/Y to 8.62bln. (Economic Times) GlaxoSmithKline Pharmaceuticals (GLXO IN) - Co. Q2 (INR) net rose 30.4% Y/Y to 3.36bln, rev. rose 20.8% Y/Y to 11.84bln. (Moneycontrol) HG Infra Engineering (HGINFRA IN) - Co. Q2 (INR) net rose 53.9% Y/Y to 798mln, rev. rose 7.6% Y/Y to 9.74bln. (Moneycontrol) Lupin (LPC IN) - Co. Q2 (INR) net fell 22.2% Y/Y to 11.55bln, rev. rose 11.1% Y/Y to 78.27bln. (Moneycontrol) Multi Commodity Exchange of India (MCX IN) - Co. Q2 (INR) net rose 130% Y/Y to 4.55bln, rev. rose 114% Y/Y to 8.00bln. (Economic Times) National Stock Exchange of India (NSE IN) - Co. Q2 (INR) net rose 23% Y/Y to 25.78bln, transaction charges rev. rose 9% Y/Y to 30.35bln, supported by higher cash market and equity options trading volumes. (Economic Times) State Bank of India (SBIN IN) - Co. Q2 (INR) net rose 14% Y/Y to 230.38bln. (Economic Times)